SOLV — Solventum Corp

NYSE · Health Care · Health Care Equipment & Supplies · CIK 1964738 ·
Last close
$78.01
Market Cap
$13.51B
52W High
$83.42
52W Low
$65.44
ADV30
1,198,926
Next earnings
2026-08-05
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 2,006,000,000 1,095,000,000 79,000,000 13,000,000 14,097,000,000 561,000,000 9,127,000,000
Dec 2025 1,998,000,000 1,027,000,000 93,000,000 63,000,000 14,294,000,000 878,000,000 9,244,000,000
Sep 2025 2,096,000,000 1,135,000,000 172,000,000 1,266,000,000 13,973,000,000 1,642,000,000 8,987,000,000
Jun 2025 2,161,000,000 1,175,000,000 214,000,000 90,000,000 15,074,000,000 492,000,000 11,429,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$152,000,000
Investing CF
$2,834,000,000
Financing CF
$-2,968,000,000
CapEx
$-354,000,000
Dividends Paid
Buybacks
$-67,000,000
EPS Diluted TTM
$8.16
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$1,810,000,000
Inventory
$1,089,000,000
Receivables
$1,180,000,000
ST Investments
EBIT TTM
$1,996,000,000
Pretax Income TTM
$1,691,000,000
Interest Exp TTM
$305,000,000
Analysts
12

Yahoo Snapshot (yfinance, live)

Total Revenue
$8,262,000,128
EBITDA
$1,124,000,000
Free Cash Flow
$377,500,000
Enterprise Value
$18,239,358,976
Total Cash
$561,000,000
Total Debt
$5,290,999,808
Shares Out
173,174,712
Trailing EPS
$8.17
Book Value
$28.64
ROE
34.8%
ROA
2.7%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 8,325,000,000 632,000,000 1,556,000,000 14,294,000,000 9,244,000,000 369,000,000
Dec 2024 8,254,000,000 1,036,000,000 479,000,000 14,457,000,000 11,498,000,000 1,185,000,000
Dec 2023 8,197,000,000 1,636,000,000 1,346,000,000 13,943,000,000 2,277,000,000 1,915,000,000
Dec 2022 8,130,000,000 1,693,000,000 1,343,000,000 13,594,000,000 1,852,000,000 1,679,000,000

TTM Snapshot

Revenues TTM
$4,156,000,000
NetIncome TTM
$582,000,000
OpCashFlow TTM
$0
Assets (Latest)
$14,457,000,000
Forward EPS
$7.09

Max Pain — expiry 2026-10-16

max pain strike: $70.00 · spot: $78.01 · call oi: 1,378 · put oi: 281
Expected Move to 2026-10-16: ±$9.85 (12.63%) — implied range $68.16$87.86 · ATM straddle on $80.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
SNN SMITH & NEPHEW PLC $12.86B $30.57
SNNUF SMITH & NEPHEW PLC $12.71B $15.10
PEN Penumbra Inc $12.54B $318.73
ALGN ALIGN TECHNOLOGY INC $11.96B $167.01
BAX BAXTER INTERNATIONAL INC $11.57B $22.40

News headlines (Yahoo Finance, 1h cache)

3 Reasons SOLV is Risky and 1 Stock to Buy Instead
2026-07-24 19:37 · Yahoo
Here's Why You Should Hold Solventum Stock in Your Portfolio for Now
2026-07-24 14:00 · Yahoo
Solventum’s Q2 2026 Earnings: What to Expect
2026-07-22 10:36 · Yahoo
3M investors are still waiting for a more 'consistent' growth story
2026-07-21 15:12 · Yahoo
Solventum to Report Second Quarter Fiscal 2026 Earnings on August 5, 2026
2026-07-15 20:05 · Yahoo
2 S&P 500 Stocks to Own for Decades and 1 We Question
2026-07-07 09:38 · Yahoo
3 Mid-Cap Stocks We Steer Clear Of
2026-06-29 10:58 · Yahoo
3 Healthcare Stocks with Questionable Fundamentals
2026-06-25 10:49 · Yahoo
Solventum Stock: Is SOLV Underperforming the Healthcare Sector?
2026-06-22 06:25 · Yahoo
Cooper Companies Stock: Is COO Underperforming the Healthcare Sector?
2026-06-16 12:07 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.